Moreover, in t(8;21)-harboring Kasumi-1 cells, multiple myeloma cell line U266 and lung cancer cell line A549, treatment with BOR also resulted in accumulation of PP2A (Figure S7). Here, PTPA is linked to plasma cell myeloma.